As shown earlier [14,17] as well as in this paper, Xen amplifies the effects of GIP on insulin, glucagon, and pancreatic polypeptide release during graded glucose infusions in humans without type 2 diabetes mellitus. This evidence concerns the gene INS and diabetes mellitus.